Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Inotiv, Inc.
  6. Company
    NOTV   US45783Q1004

INOTIV, INC.

(NOTV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Inotiv, Inc.
Inotiv, Inc, formerly Bioanalytical systems, Inc., is an international contract research company providing drug discovery and development services and analytical instruments. The Company focuses on providing drug developers with scientific research and analytical instrumentation. The Company operates in two segments: research services and research products. The research services segment provides research and development support on a contract basis directly to pharmaceutical companies. The research products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. The Company supports both the non-clinical and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, but also including biotherapeutics and devices.

Number of employees : 421 people.
Sales per Business
20192020Delta
USD (in Million)%USD (in Million)%
Services39.0589.5%57.1894.6% +46.43%
Products4.5710.5%3.295.4% -27.93%
Sales per region
20192020Delta
USD (in Million)%USD (in Million)%
United States39.6390.9%56.2593% +41.93%
Pacific Rim2.415.5%2.834.7% +17.41%
Europe1.222.8%1.212% -0.82%
Other North America0.2180.5%0.1480.2% -32.11%
Other0.1400.3%0.0350.1% -75%
Managers
NameAgeSinceTitle
Robert Leasure602019President, Chief Executive Officer & Director
Beth A. Taylor542020Chief Financial Officer, Secretary & VP-Finance
John Gregory Beattie532021Chief Operating Officer
Richard Allen Johnson, Dr.742012Independent Director
Gregory C. Davis, Dr.662017Chairman
R. Matthew Neff642017Independent Director
John E. Sagartz, Dr.552018Independent Director & Chief Strategy Officer
Kimberly Beaty--Senior Director-Marketing
Candace A. Rohde Johnson-2017Director-InVivo Products & Services
Philip A. Downing-2019Senior Vice President-Preclinical Services
Members of the board
NameAgeSinceTitle
Gregory C. Davis, Dr.662017Chairman
Richard Allen Johnson, Dr.742012Independent Director
R. Matthew Neff642017Independent Director
John E. Sagartz, Dr.552018Independent Director & Chief Strategy Officer
Robert Leasure602019President, Chief Executive Officer & Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 15,827,839 9,857,969 62.3% 0 0.0% 62.3%
Stock B 0 25 0 0.0% 0 0.0%
Shareholders
NameEquities%
Peter T. Kissinger 1,285,767 8.12%
Phillip Bendele 837,639 5.29%
Renaissance Technologies LLC 681,165 4.30%
John E. Sagartz 648,524 4.10%
estate of Hamot Seth W 636,621 4.02%
Kimberly L Sagartz 634,759 4.01%
Next Century Growth Investors LLC 625,016 3.95%
The Vanguard Group, Inc. 371,461 2.35%
Healthinvest Partners AB 320,234 2.02%
IsZo Capital Management LP 313,522 1.98%
Sector Other Biotechnology & Medical Research
1st jan.Capitalization (M$)
INOTIV, INC.0.00%484
MODERNA, INC.89.37%79 438
LONZA GROUP AG17.02%54 990
IQVIA HOLDINGS INC.36.31%46 809
CELLTRION, INC.-24.37%33 149
SEAGEN INC.-13.60%27 461
HANGZHOU TIGERMED CONSULTING CO., LTD10.14%23 290
PHARMARON BEIJING CO., LTD.55.10%22 324
CUREVAC N.V.16.92%21 497
ALNYLAM PHARMACEUTICALS, INC.29.49%19 783
INCYTE CORPORATION-4.85%18 280
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.41.82%17 735
BIO-TECHNE CORPORATION39.36%17 211
PPD, INC.35.45%16 278
NOVAVAX, INC.58.05%13 054
ICON PUBLIC LIMITED COMPANY7.99%11 130
QIAGEN N.V.-9.12%10 970
PRA HEALTH SCIENCES, INC.32.68%10 785
CRISPR THERAPEUTICS AG-19.07%9 928
SYNEOS HEALTH, INC.24.48%8 763
GENSCRIPT BIOTECH CORPORATION181.03%8 473